ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Organ Systems Extension to CNS, Aerodigestive Tract Considered

July 26, 1985

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

January 6, 1978

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

In Brief: Reynolds Retires “Joe Camel” advertising; Slaga Moves Lab To MC Cancer Center

July 18, 1997

FDA says new tools needed to speed therapeutics development.

March 26, 2004